• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275

Introduction to N-(1-Methylpropyl)-4-piperidinecarboxamide (CAS No. 884497-62-5)

N-(1-Methylpropyl)-4-piperidinecarboxamide, a compound with the chemical formula C₉H₁₇N₂O, is a derivative of piperidine that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number 884497-62-5, is characterized by its unique structural and pharmacological properties, making it a promising candidate for various therapeutic applications.

The molecular structure of N-(1-Methylpropyl)-4-piperidinecarboxamide features a piperidine ring substituted with a carboxamide group at the 4-position and an isobutyl group at the 1-position. This configuration contributes to its distinct chemical behavior and biological activity. The presence of the piperidine core is particularly noteworthy, as piperidine derivatives are widely recognized for their role in medicinal chemistry due to their ability to modulate biological targets effectively.

In recent years, there has been a growing interest in exploring the pharmacological potential of N-(1-Methylpropyl)-4-piperidinecarboxamide. Its unique structural features suggest that it may interact with a variety of biological targets, including enzymes and receptors involved in neurotransmitter signaling. This has led to extensive research into its potential applications in the treatment of neurological disorders, such as depression, anxiety, and neurodegenerative diseases.

One of the most compelling aspects of N-(1-Methylpropyl)-4-piperidinecarboxamide is its potential as a scaffold for drug discovery. The piperidine ring provides a versatile platform for chemical modification, allowing researchers to fine-tune its pharmacological properties. This flexibility has enabled the development of several analogs with enhanced efficacy and reduced side effects. For instance, modifications at the carboxamide group have been shown to improve solubility and bioavailability, critical factors for drug formulation.

Recent studies have highlighted the compound's interaction with serotonin receptors, particularly the 5-HT_1A receptor, which is implicated in mood regulation and cognitive function. N-(1-Methylpropyl)-4-piperidinecarboxamide has demonstrated promising binding affinity to this receptor, suggesting its potential as an agonist or partial agonist in therapeutic contexts. This finding aligns with the increasing interest in serotonergic agents for treating mental health disorders.

The compound's pharmacokinetic profile is another area of active investigation. Preliminary studies indicate that N-(1-Methylpropyl)-4-piperidinecarboxamide exhibits favorable metabolic stability and moderate oral bioavailability. These properties are essential for developing drugs that can be administered orally and maintain therapeutic levels over an extended period. Additionally, its low toxicity profile makes it an attractive candidate for further clinical development.

In vitro studies have also explored the potential of N-(1-Methylpropyl)-4-piperidinecarboxamide as an anti-inflammatory agent. The piperidine core has been shown to interact with inflammatory pathways, suggesting that this compound may have therapeutic benefits in conditions such as rheumatoid arthritis and inflammatory bowel disease. These findings open up new avenues for research into novel anti-inflammatory therapies.

The synthesis of N-(1-Methylpropyl)-4-piperidinecarboxamide presents unique challenges due to its complex structure. However, advances in synthetic chemistry have made it possible to produce this compound with high purity and yield. Techniques such as multi-step organic synthesis and catalytic processes have been employed to optimize production methods. These advancements are crucial for ensuring an adequate supply of the compound for both research and potential clinical use.

The future direction of research on N-(1-Methylpropyl)-4-piperidinecarboxamide is likely to focus on expanding its therapeutic applications. Investigating its interactions with other biological targets, such as ion channels and G protein-coupled receptors, could uncover additional pharmacological effects. Furthermore, exploring combination therapies involving this compound with other drugs may lead to synergistic benefits in treating complex diseases.

In conclusion, N-(1-Methylpropyl)-4-piperidinecarboxamide (CAS No. 884497-62-5) is a structurally intriguing compound with significant potential in pharmaceutical applications. Its unique properties make it a valuable tool for drug discovery and development, particularly in the treatment of neurological and inflammatory disorders. As research continues to uncover new insights into its pharmacological profile, this compound is poised to play a crucial role in advancing therapeutic strategies.

• 179683-97-7(2-Piperidinone,3,5-dimethyl-)
• 3768-43-2(3-Methylpiperidin-2-one)
• 29553-51-3(3-Methylpiperidine-2,6-dione)
• 3306-69-2(2-Azabicyclo[2.2.2]octan-3-one)
• 134003-03-5((1S,4R)-2-Azabicyclo[2.2.1]heptan-3-one)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)